Unknown

Dataset Information

0

Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model.

ABSTRACT: Crigler-Najjar syndrome type I (CNSI) is a rare monogenic disease characterized by severe neonatal unconjugated hyperbilirubinemia with a lifelong risk of neurological damage and death. Liver transplantation is the only curative option, which has several limitations and risks. We applied an in vivo gene targeting approach based on the insertion, without the use of nucleases, of a promoterless therapeutic cDNA into the albumin locus of a mouse model reproducing all major features of CNSI Neonatal transduction with the donor vector resulted in the complete rescue from neonatal lethality, with a therapeutic reduction in plasma bilirubin lasting for at least 12 months, the latest time point analyzed. Mutant mice, which expressed about 5-6% of WT Ugt1a1 levels, showed normal liver histology and motor-coordination abilities, suggesting no functional liver or brain abnormalities. These results proved that the promoterless gene therapy is applicable for CNSI, providing therapeutic levels of an intracellular ER membrane-bound enzyme responsible for a lethal liver metabolic disease.

SUBMITTER: Porro F 

PROVIDER: S-EPMC5623861 | biostudies-other | 2017 Oct

REPOSITORIES: biostudies-other

Json Xml
altmetric image

Publications

Promoterless gene targeting without nucleases rescues lethality of a Crigler-Najjar syndrome mouse model.

Porro Fabiola F   Bortolussi Giulia G   Barzel Adi A   De Caneva Alessia A   Iaconcig Alessandra A   Vodret Simone S   Zentilin Lorena L   Kay Mark A MA   Muro Andrés F AF  

EMBO molecular medicine 20171001 10

Crigler-Najjar syndrome type I (CNSI) is a rare monogenic disease characterized by severe neonatal unconjugated hyperbilirubinemia with a lifelong risk of neurological damage and death. Liver transplantation is the only curative option, which has several limitations and risks. We applied an <i>in vivo</i> gene targeting approach based on the insertion, without the use of nucleases, of a promoterless therapeutic cDNA into the albumin locus of a mouse model reproducing all major features of CNSI N  ...[more]